Medical Cannabis

is the President and Founder, jCanna, Inc. and Cannabis Science Conference. He is also a contributing editor for Cannabis Science & Technology.

Articles

A review on a handful of recent articles related to COVID-19 and cannabis as well as an interview with a top medical cannabis expert—Dr. Prakash Nagarkatti.

A Storm of Research Activity into Cannabis and Coronavirus A Closer Look at Expanding Research of Cannabinoids and Terpenes in COVID-19

Tilray, Inc. announced that one of their GMP products is showing a potential benefit in reducing nausea and vomiting caused by chemotherapy.

Tilray Medical Cannabis Product Shows Promising Results on Chemotherapy Side Effects

An interview with Dr. Bonni Goldstein on treating patients during a pandemic, telemedicine, cannabis research, and more.

Treating Immunocompromised Patients During the COVID-19 Pandemic:  A Conversation with Dr. Bonni Goldstein

An interview with an amazing family of four doctors—the Knox Docs—who are key opinion leaders in cannabis therapeutics, endocannabinology, and cannabinoid medicine.

The First Family of Cannabinoid Medicine: The Knox Docs

A tribute piece to Charlotte Figi, a medical cannabis and CBD pioneer who inspired the name of the medical cannabis strain Charlotte’s Web.

A Tribute to the Life and Legacy of Charlotte Figi

Kentucky Passes Medical Cannabis Legislation

Dr. Sue Sisley has been pioneering research in the U.S. cannabis industry and fighting for quality cannabis samples to conduct her clinical trials. We recently spoke to her about the challenges she’s faced, what’s ahead for her future research, and more.

Dr. Sue Sisley: Advocating for Medical Cannabis Research, Patients, and Reform 

is a Full Professor and Shimadzu Distinguished Professor of Analytical Chemistry in the Department of Chemistry & Biochemistry at The University of Texas (UT) at Arlington.

Commentary on how medicinal cannabis can evolve in a similar manner as the pharmaceutical industry did.

Beyond THC and CBD: Opportunities for Creating Pharmaceutical Targets

A long history of cannabis discoveries and research has put Israel at the forefront of medical cannabis developments, worldwide collaborations, and investor activity.

Cannabis 2.0 in Israel: “Elevating Everything”

Aryn Sieber, the founder and CEO of CBD Essentials and Cannaisseur Brands as well as the founder of CannaCauses Foundation, discusses his experiences as a 9/11 first responder, his battle with stage IV cancer, and how cannabis impacted his life.